Cancer drugs tested for use against zoonotic bioweapons

04/7/2013 | FoxNews.com

Zoonotic illnesses such as monkeypox and Ebola are potential bioweapons, and the Defense Threat Reduction Agency is funding research into how two cancer medications -- Gleevec and Tasigna -- could serve as a defense against such attacks. The idea is that the drugs could slow an infection, allowing the immune system to mount an effective response. Scientists hope to develop a general defense against a variety of potential bioweapons because producing a separate drug for use against each agent is not practical.

View Full Article in:

FoxNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX